Athira Pharma (ATHA) Earnings Date, Estimates & Call Transcripts $0.57 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Athira Pharma Latest Earnings SummaryActual EPS (Nov. 7) -$0.75 Beat By $0.05 Consensus EPS (Nov. 7) -$0.80 Athira Pharma released Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.75, which topped the consensus estimate of -$0.80 by $0.05. With a trailing EPS of -$2.85, Athira Pharma's earnings are expected to grow next year, from ($2.35) to ($0.82) per share. Get Athira Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Athira Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataATHA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ATHA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Athira Pharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.35) EPSNext Year EPS Consensus Estimate: ($0.82) EPS Athira Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/7/2024--$0.80-$0.75+$0.05-$0.75--8/1/2024--$0.75-$0.70+$0.05-$0.70--5/15/2024--$0.80-$0.69+$0.11-$0.69--2/22/2024Q4 2023-$0.96-$0.71+$0.25-$0.71--11/9/2023Q3 2023-$0.87-$0.87--$0.87--8/10/2023Q2 2023-$0.81-$0.78+$0.03-$0.78-- Get the Latest News and Ratings for ATHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Athira Pharma and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023-$0.66-$0.73 -$0.07-$0.73--3/23/2023Q4 2022-$0.70-$0.79 -$0.09-$0.79-- Athira Pharma Earnings - Frequently Asked Questions When did Athira Pharma announce their last quarterly earnings? Athira Pharma (NASDAQ:ATHA) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on ATHA's earnings history. Did Athira Pharma beat their earnings estimates last quarter? In the previous quarter, Athira Pharma (NASDAQ:ATHA) reported ($0.75) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.80) by $0.05. Learn more on analysts' earnings estimate vs. ATHA's actual earnings. How much profit does Athira Pharma generate each year? Athira Pharma (NASDAQ:ATHA) has a recorded net income of -$117.67 million. ATHA has generated -$2.85 earnings per share over the last four quarters. What is Athira Pharma's EPS forecast for next year? Athira Pharma's earnings are expected to grow from ($2.35) per share to ($0.82) per share in the next year. More Earnings Resources from MarketBeat Related Companies Unicycive Therapeutics Earnings Assertio Earnings Genelux Earnings Quince Therapeutics Earnings Theratechnologies Earnings Anixa Biosciences Earnings ESSA Pharma Earnings Journey Medical Earnings CytomX Therapeutics Earnings Avalo Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles S&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough This page (NASDAQ:ATHA) was last updated on 1/6/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$24 trillion tech spotted at Mar-a-Lago?President Trump’s Secret Service was recently spotted using an odd new technology at his home in Mar-a-Lago…Centurion Publishing | SponsoredFrom bankrupt to delivering 610,000% returnsWalk the empty streets of this barren town and you would have no idea that behind the sand-scarred blight is o...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athira Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athira Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
